PAPER Asi YT, Simpson JE, Heath PR, Wharton SB, Lees AJ, Revesz T, Houlden H, Holton JL
SEARCH RESULTS
330026 RESULTS
PAPER Austin JA, Wright GS, Watanabe S, Grossmann JG, Antonyuk SV, Yamanaka K, Hasnain SS
Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life.
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4309-14. Epub 2014 Mar 3 PubMed: 24591609PAPER Winkler EA, Sengillo JD, Sagare AP, Zhao Z, Ma Q, Zuniga E, Wang Y, Zhong Z, Sullivan JS, Griffin JH, Cleveland DW, Zlokovic BV
Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice.
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):E1035-42. Epub 2014 Mar 3 PubMed: 24591593PAPER Dalla Bella E, Rigamonti A, Mantero V, Morbin M, Saccucci S, Gellera C, Mora G, Lauria G
Heterozygous D90A-SOD1 mutation in a patient with facial onset sensory motor neuronopathy (FOSMN) syndrome: a bridge to amyotrophic lateral sclerosis.
J Neurol Neurosurg Psychiatry. 2014 Sep;85(9):1009-11. Epub 2014 Mar 3 PubMed: 24591457PAPER Albert SM
Amyotrophic lateral sclerosis: a patient care guide for clinicians (book).
Neurology. 2014 Mar 4;82(9) PubMed: 24590250PAPER Zhang KY, Yang S, Warraich ST, Blair IP
Ubiquilin 2: a component of the ubiquitin-proteasome system with an emerging role in neurodegeneration.
Int J Biochem Cell Biol. 2014 May;50:123-6. Epub 2014 Feb 28 PubMed: 24589709PAPER Berry JD, Cudkowicz ME, Shefner JM
Predicting success: optimizing phase II ALS trials for the transition to phase III.
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):1-8. PubMed: 24588460PAPER Health Quality Ontario
The appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysis.
Ont Health Technol Assess Ser. 2014;14(1):1-64. Epub 2014 Feb 1 PubMed: 24592296PAPER Hernandez-Rapp J, Martin-Lannerée S, Hirsch TZ, Launay JM, Mouillet-Richard S
Hijacking PrP(c)-dependent signal transduction: when prions impair Aβ clearance.
Front Aging Neurosci. 2014;6:25. Epub 2014 Feb 28 PubMed: 24592237PAPER Barbato C, Pezzola S, Caggiano C, Antonelli M, Frisone P, Ciotti MT, Ruberti F
A lentiviral sponge for miR-101 regulates RanBP9 expression and amyloid precursor protein metabolism in hippocampal neurons.
Front Cell Neurosci. 2014;8:37. Epub 2014 Feb 13 PubMed: 24592211PAPER Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM
Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease.
Neuropsychiatr Dis Treat. 2014;10:391-401. Epub 2014 Feb 21 PubMed: 24591834PAPER Matlack KE, Tardiff DF, Narayan P, Hamamichi S, Caldwell KA, Caldwell GA, Lindquist S
Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity.
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4013-8. Epub 2014 Mar 3 PubMed: 24591589PAPER Modh RP, Kumar SP, Jasrai YT, Chikhalia KH
Design, synthesis, biological evaluation, and molecular modeling of coumarin-piperazine derivatives as acetylcholinesterase inhibitors.
Arch Pharm (Weinheim). 2013 Nov;346(11):793-804. Epub 2013 Oct 8 PubMed: 24591157PAPER Yi R, Zhan XR, Tang J, Zhang LM, Liu XM, Dong Q
EEG Synchronization Evaluation: A New Diagnostic Tool for Predicting the Progression of Alzheimer's disease.
Clin EEG Neurosci. 2015 Apr;46(2):130-5. Epub 2014 Mar 3 PubMed: 24590871PAPER Jiang S, Li Y, Zhang C, Zhao Y, Bu G, Xu H, Zhang YW
M1 muscarinic acetylcholine receptor in Alzheimer's disease.
Neurosci Bull. 2014 Apr;30(2):295-307. Epub 2014 Mar 3 PubMed: 24590577Current Filters
No filters selected